Online ISSN: 1947-6027
About Genes & Cancer
Our mission is to combine research from the fields of genomics, bioinformatics, and modem genetics to determine how cancer cells overcome growth regulatory pathways. We aim to cover all aspects of oncogenes, growth suppressor and apoptotic genes, and their roles in tumor development.

Genes & Cancer | CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens

Genes & Cancer

February 10, 2023
PRESS RELEASE: A new review was published in Genes & Cancer on February 1, 2023, entitled, “CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens.” continue reading »

Genes & Cancer | Leveraging Allogeneic Dendritic Cells for Neoantigen Cancer Vaccines

News

February 3, 2023
PRESS RELEASE: On January 30, 2023, a new research perspective was published in Genes & Cancer, entitled, “Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines.” continue reading »

Genes & Cancer | Slit2 signaling stimulates Ewing sarcoma growth

Genes & Cancer

January 13, 2023
PRESS RELEASE: On December 14, 2022, a new research paper was published in Genes & Cancer, entitled, “Slit2 signaling stimulates Ewing sarcoma growth.” continue reading »

Genes & Cancer | Pathogenesis to management of hepatocellular carcinoma

Genes & Cancer

January 6, 2023
PRESS RELEASE: On December 13, 2022, Genes & Cancer published a new review, entitled, “Pathogenesis to management of hepatocellular carcinoma.” continue reading »

Genes & Cancer | Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors

Genes & Cancer

December 16, 2022
PRESS RELEASE: On December 2, 2022, a new research paper was published in Genes & Cancer, entitled, “Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors.” continue reading »